Sarepta Therapeutics (SRPT) Revenue (2017 - 2025)
Historic Revenue for Sarepta Therapeutics (SRPT) over the last 12 years, with Q2 2025 value amounting to $611.1 million.
- Sarepta Therapeutics' Revenue rose 6837.66% to $611.1 million in Q2 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 1577.99%. This contributed to the annual value of $1.9 billion for FY2024, which is 5297.39% up from last year.
- Latest data reveals that Sarepta Therapeutics reported Revenue of $611.1 million as of Q2 2025, which was up 6837.66% from $112.0 million recorded in Q1 2025.
- In the past 5 years, Sarepta Therapeutics' Revenue ranged from a high of $658.4 million in Q4 2024 and a low of $112.0 million during Q1 2025
- In the last 5 years, Sarepta Therapeutics' Revenue had a median value of $256.0 million in 2022 and averaged $305.7 million.
- Data for Sarepta Therapeutics' Revenue shows a peak YoY increase of 6837.66% (in 2025) and a maximum YoY decrease of 7291.18% (in 2025) over the last 5 years.
- Quarter analysis of 5 years shows Sarepta Therapeutics' Revenue stood at $201.5 million in 2021, then increased by 28.28% to $258.4 million in 2022, then soared by 53.54% to $396.8 million in 2023, then surged by 65.94% to $658.4 million in 2024, then dropped by 7.19% to $611.1 million in 2025.
- Its Revenue was $611.1 million in Q2 2025, compared to $112.0 million in Q1 2025 and $658.4 million in Q4 2024.